Expanded Access to Ensartinib for Participants With ALK+ NSCLC
Clinical trial NCT04146571 · AVAILABLE
Trial details
- NCT number
- NCT04146571
- Sponsor
- Xcovery Holdings, Inc.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.